Cboe Global Markets (CBOE)
BATSFinancialsFinancial Data & Stock ExchangesSnapshot 2026-07-08
$264.41+2.23%
Close 2026-07-08 · 1-day change
Reading CBOE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CBOE free→BATSFinancialsFinancial Data & Stock ExchangesSnapshot 2026-07-08
Reading CBOE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CBOE free→QuarterlyIQ Insights · CBOE
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $264.41. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $259 the market pays 22× p/e — above the 17× p/e peer median but in line with its own 22× history. That premium reflects a durable franchise our peer-anchored $231 fair value understates; treat the 'expensive vs peers' read with medium confidence. Analysts target $263–$395. Note: our $231 fair value sits below the entire analyst range ($263–$395). Not investment advice.
$263.00 – $395.00 (median $335.00) · 11 analysts · as of 2026-06-22
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $335.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $97.80 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $107.54 | — | — | Hist. CAGR | high |
| graham number | 12M | $117.01 | — | — | TTM | high |
| Peer P/B | 12M | $106.82 | 2.1 | 51.18 | TTM | high |
| Peer P/FCF | 12M | $123.06 | 13.2 | 9.29 | TTM | high |
| Peer P/E | 12M | $189.43 | 15.9 | 11.89 | TTM | high |
| Peer P/S | 12M | $149.35 | 3.3 | 45.64 | TTM | high |
| PEG | 12M | $311.28 | 26.2 | 11.89 | TTM | high |
| residual income | 12M | $78.20 | — | — | TTM | high |
| Own P/E history | 12M | $265.04 | 22.3 | 11.89 | TTM | high |
| triangulated | 12M | $181.98 | 15.9 | 11.42 | Triangulated | high |
| Peer P/B | 3Y | $162.20 | 2.1 | 77.71 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $103.27 | 13.2 | 7.80 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $264.83 | 15.9 | 16.62 | Analyst | medium |
| Peer P/S | 3Y | $188.14 | 3.3 | 57.49 | guidance | medium |
| PEG | 3Y | $435.19 | 26.2 | 16.62 | Analyst | medium |
| Own P/E history | 3Y | $370.54 | 22.3 | 16.62 | Analyst | medium |
| Peer P/B | 5Y | $214.29 | 2.1 | 102.67 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $91.88 | 13.2 | 6.94 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $308.90 | 15.9 | 19.39 | Analyst | high |
| Peer P/S | 5Y | $219.44 | 3.3 | 67.06 | guidance | high |
| PEG | 5Y | $507.61 | 26.2 | 19.39 | Analyst | high |
| Own P/E history | 5Y | $432.20 | 22.3 | 19.39 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.